A surprise at this year’s Thanksgiving dinner was that a majority of my friends (who do not work in biopharma) at the dinner table heard about the FDA warning letter issued to 23 & Me, a biotechnology company that offers a direct-to-consumer genome test kit. Almost all of them have used the kit and find […]
Tag Archives: pharma
- Beyond16,000 #ASCO13 tweets: leveraging the use of social media for ASCO and the oncology community
- Twitter: A Social Soundtrack for Medical Meetings
- Big Data and healthcare PR: from volume to value
- Venture capital indicates trends of digital health
- Reading medical journals can actually be fun: how digital and social media transforms medical journal publishing
- Why Foreign Companies Should Take Chinese Social Media Seriously
- FDA Warning Letter Highlights Disconnect Between Regulator & Biotech Industry
- Reducing Health Care Costs: It’s About Time to Try What has Worked
- Trust is What Makes Health Care Work–A Success Story from Belgium
- Physician Communication and Patient-centered Care: What Healthcare Provider Organizations Can Do to Improve Internal Communication
-
kcoxinbk: Interesting- and scary- because if it's TRUST that…
-
Mayra Mejia, MS: Reblogged this on digitalvisionmd.com.…
-
Editor: Reblogged this on Health Care Social Media Monitor…
-
Helen Adamopoulos (@BHR_Adamop): Great post. I covered this issue as well: http://b…
- Healthcare Communication Industry Tests New Offerings as Health Care Reform Evolves | Thoughts From Broad Street: […] few weeks ago, I wrote an article about …
